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Utilisation of outpatient medical services by people with  
diagnosed diabetes during the COVID-19 pandemic in Germany
Abstract
People with diabetes regularly need outpatient medical care due to their disease and possible concomitant and secondary 
illnesses. Using data from the nationwide GEDA 2019/2020-EHIS survey conducted from April 2019 to September 2020, 
the present study examines developments in outpatient utilisation behaviour during the measures put in place to contain 
the SARS-CoV-2 pandemic. During the observation period, people with diabetes had a significantly higher rate of utilisation 
of medical services provided by general practitioners (GPs) and specialists than the population as a whole. In the spring 
of 2020, when the restrictions were put in place, utilisation of specialist medical services by people with diabetes decreased 
temporarily by 46% compared to the 2019 reference period. In contrast, no relevant decline in the utilisation of medical 
services provided by GPs was observed, but this could be related to adaptations of care provision through telephone 
consultations for people with regularly requiring GP office visits. The issue examined here requires further observations 
in view of the renewed containment measures.
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Introduction
Since the beginning of 2020, SARS-CoV-2 has also been 
spreading in Germany. In addition to general hygiene mea-
sures, observing social distancing rules and wearing a mouth 
and nose cover, certain phases of stricter contact restrictions 
have been put in place during the pandemic as part of the 
non-pharmaceutical measures aiming at containing SARS-
CoV-2 infection. In March 2020, the German government in 
agreement with the federal states decided to implement com-
prehensive measures for infection control and capacity redis-
tribution for outpatient and inpatient care in addition to gen-
eral contact restrictions. These measures were gradually 
phased out between the end of April 2020 and the end of 
October 2020, but were put in place again in November 2020 
[1]. Accounting data from the statutory health insurance (SHI) 
and the Associations of SHI Physicians (Kassen ärztliche 
Vereinigungen) show that these measures have had an 
impact on the provision of outpatient and inpatient care [2–4]. 
However, until now, very limited information has been avail-
able on utilisation behaviour by people with chronic illnesses 
[4, 5]. Results from the closely conducted telephone-based 
COSMO (COVID-19 Snapshot Monitoring) survey indicate 
that the majority of adults with chronic illnesses were able 
to attend necessary doctor’s appointments and receive nec-
essary medications largely without restrictions during the 
first stage of the containment measures [5].
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People with diabetes mellitus belong to the group of 
chronically ill people and need continuous medical care. 
They also belong to the risk group for severe courses of 
COVID-19 [6–9]. This particularly applies to those who have 
poor control of their blood sugar levels or complications, 
regardless of whether they have type 1 or type 2 diabetes 
[6]. Fear of being infected with SARS-CoV-2 and changes 
in the health care delivery may have led people with diabe-
tes to avoid visiting a doctor’s office. Further, it is impor-
tant to understand how long such changes in health care 
utilisation have lasted.
The present study uses data from the nationwide, pop-
ulation-based GEDA 2019/2020-EHIS study to help answer 
the following questions: (1) How has the use of general 
practitioner (GP) and specialist services developed among 
people with diabetes during the observation period from 
April 2019 to September 2020? and (2) Was there a reduc-
tion in health care utilisation among people with diabetes 
during the containment measure period in the spring of 
2020 compared to the corresponding period in 2019?
Indicator
Definition of the indicators on the utilisation of outpatient 
GP and specialist services was based on the answers of 
participants to the questions about visits to GPs and spe-
cialists in the four weeks prior to the interview. Informa-
tion on the utilisation of medical services provided by GPs 
was collected using the question ‘How often have you 
consulted a GP in the last 4 weeks for advice, an exami-
nation or treatment?’; this question was accompanied by 
the following note: ‘Please include visits to medical prac-
tices, home visits and consultations provided over the 
telephone’. Data on the utilisation of specialist medical 
services was collected using an adapted version of the 
same question and was accompanied by the following 
note: ‘This does not include visits to a dentist or general 
practitioner’. The answers provided were used to estab-
lish two dichotomous variables which differentiated 
between people who had or had not used medical services 
provided by a GP or specialist. Diabetes status was deter-
mined using answers from the question ‘Have you had 
any of the following illnesses or complaints in the last 12 
months?’. The answer categories provided a list of dis-
eases and conditions, one of which was ‘diabetes (not 
including gestational diabetes)’. The survey did not col-
lect any data about diabetes type, duration of illness, treat-
ment (insulin, tablets and combinations) or diabetes-spe-
cific complications.
The following analyses are based on data from GEDA 
2019/2020-EHIS, which was carried out as a telephone 
survey of the resident population in Germany aged 15 years 
or above [10]. The sample comprised 23,001 individuals 
who participated in the survey during the period of April 
2019 to September 2020. No information was available for 
192 participants on diabetes status or utilisation of medi-
cal services provided by GPs or specialists. Of the remain-
ing 22,809 participants, a total of 2,044 (938 women, 1,106 
men) who reported diabetes in the last twelve months were 
included in this analysis. A period of the twelve calendar 
weeks (CW) from CW 15 to CW 26 (i.e. beginning of April 
through end of June) in 2020 was considered as the time 
period of containment measures. Since utilisation of medi-
cal services can be affected by the seasons, the same period 
from CW 15 to CW 26 in 2019 was used as comparison 
GEDA 2019/2020-EHIS  
Fifth follow-up survey of the  
German Health Update
Data holder: Robert Koch Institute
Objectives: Provision of reliable information on 
the health status, health behaviour and health 
care of the population living in Germany, with 
the possibility of European comparisons 
Study design: Cross-sectional telephone survey 
Population: German-speaking population aged 
15 and older living in private households that 
can be reached via landline or mobile phone
Sampling: Random sample of landline and 
mobile telephone numbers (dual-frame 
method) from the ADM sampling system 
(Arbeitskreis Deutscher Markt- und Sozialfor-
schungsinstitute e.V.)
Sample size: 23,001 respondents
Study period: April 2019 to September 2020
GEDA survey waves: 
  GEDA 2009
  GEDA 2010
  GEDA 2012
  GEDA 2014/2015-EHIS
  GEDA 2019/2020-EHIS
Further information in German is available at 
www.geda-studie.de
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During the observation period of April 2019 to September 
2020, a total of 58.1% (95% CI 54.5%–61.7%) of respon-
dents who had diabetes in the last twelve months used 
medical services provided by a GP in the last four weeks 
prior to their interview, 32.9% (95% CI 29.8%–36.1%) used 
medical services provided by a specialist.
Figure 1 demonstrates fluctuations in the monthly figures 
on the utilisation of medical services provided by GPs and 
specialists for people with diabetes. In addition to the sea-
sonal fluctuations that are also seen among the general pop-
ulation [10], the monthly fluctuations are at least partly due 
to the relatively low number of cases available for this study. 
In terms of the utilisation of medical services provided by 
GPs, one of the highest monthly values can be seen in March 
2020; this is followed by a clear, short-term decline in April 
2020 to one of the lowest monthly values, before an equally 
clear, rapid increase in utilisation from May 2020. This 
results in an overall relatively horizontal smoothed curve for 
the period from CW 15 to 26 of 2020. In contrast, a very low 
monthly value in April 2020 is followed by similarly low 
monthly values in May and June 2020 for the utilisation of 
specialist medical services; then it increases again from July 
2020. This is reflected in the lowest point of the smoothed 
curve for the period from CW 15 to 26 of 2020. A compari-
son of CW 15 to 26 in 2019 and 2020 found no statistically 
significant difference in the adjusted proportions of utilisa-
tion of medical services provided by GPs (58.8%, 95% CI 
50.3%–67.3% vs. 62.0%, 95% CI 54.8%–69.3%). However, 
it did highlight a significant reduction in the utilisation of 
specialist services, which dropped by 46% from 43.4% (95% 
CI 34.4%–52, 3%) to 23.6% (95% CI 17.6%–29.7%).
period to examine the potential impact of the pandemic 
on the utilisation of medical services [10]. The analysis for 
health care utilisation from CW 15 to CW 26 are based on 
the responses of 256 people with diabetes in 2019 and 351 
people with diabetes in 2020.
In order to map possible changes in the utilisation of 
outpatient GP and specialist medical services during the 
observation period from April 2019 to September 2020, 
three logistic regression models were fitted each with age, 
sex, education and federal state as independent control 
variables (adjustment). A detailed description of the mod-
elling undertaken and the software used has been pub-
lished elsewhere [10]. The models allow estimation of 
adjusted proportions and 95% confidence intervals (CI) for 
the utilisation of GP and specialists medical services 
monthly (model 1) and weekly (smoothed, i.e. weekly fluc-
tuations adjusted in proportions, model 2) for the entire 
observation period from April (CW 14) 2019 to September 
(CW 36) 2020 as well as for the comparison periods from 
CW 15 to 26 in 2019 and 2020 (model 3). A significant dif-
ference between the comparison periods is assumed if the 
p-value of the binary variable used to differentiate between 
the periods is <0.05. The analysis was done using survey 
procedures. A weighting factor was used throughout the 
analysis, which corrected deviations from the population 
structure in terms of the distribution of age, sex, federal 
state and district type as of 31 December 2018 as well as 
the distribution of education according to the International 
Standard Classification of Education (ISCED classification) 
in the 2018 microcensus; the survey dates before and after 
the containment measures came into force were also taken 
into account here [10].
The utilisation of specialist 
medical services by people 
with diabetes significantly 
declined during the  
containment period.
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the population as a whole is plausible due to their con-
tinuous need for health care. Further, people with diabe-
tes also tend to be older, and thus have more health prob-
lems. In the general population, the smoothed curves for 
GP and specialist service utilisation run almost parallel 
to one another throughout almost the entire observation 
period with each curve reaching its lowest point within 
the period of containment measures. Among people with 
diabetes, with the exception of the ends of the smoothed 
curves (as these values are difficult to interpret due to 
small number of cases and resulting broad confidence 
In a previous, comparable study conducted among the 
general population, the proportion for the utilisation of 
medical services provided by GPs or specialists in the 
period from April 2019 to September 2020 was consis-
tently lower [10] than that among people with diabetes in 
the present study. In addition, a comparison of CW 15 to 
26 in 2019 and 2020 based on the general population 
observed a temporary reduction in the utilisation of med-
ical services provided by GPs (38.4% vs. 29.7%) and spe-
cialists (30.0% vs. 17.7%) [10]. The overall significantly 
higher rate of utilisation by people with diabetes than by 






































































































Points with vertical lines = monthly percentages with 95% CI, lines with tunnel = smoothed weekly percentages with 95% CI
CW = calendar week, CI = confidence interval 
* adjusted for age, sex, education and federal state
General practitioner services Specialist medical services
Month Calendar week smoothed Month Calendar week smoothed
Figure 1 
Outpatient medical services utilisation in the 
last four weeks by people with diabetes in the 
observation period between April 2019 and 
September 2020 (adjusted proportions*) 
Source: GEDA 2019/2020-EHIS 
The utilisation of specialist 
medical services by people 
with diabetes began to 
increase again once the 
measures were relaxed.
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and neurological examinations) cannot be carried out in 
this manner [13]. From the end of May 2020, therefore, 
accounting data also indicates that direct face-to-face 
contacts to patients increased again across all medical 
specialty groups. 
In summary, during the first phase of the measures put 
in place to contain the SARS-CoV-2 pandemic (spring 2020), 
utilisation of medical services provided by GPs and spe-
cialists to the general population temporarily decreased 
compared to the same period in 2019. In contrast, utilisa-
tion of medical services provided by GPs to people with 
diabetes remained at a similar level to 2019, and this may 
be due to fewer patients forgoing their regular treatment, 
or the use of telephone consultations. In the spring of 2020, 
utilisation of medical services provided by specialists to 
people with diabetes decreased by 46% compared to the 
corresponding period in 2019; however, it rose again quickly 
from July 2020, which may indicate that patients began to 
visit practices again. Further observation of utilisation- 
related behaviour, but also of the self-assessed quality of 
care of diabetes and other chronic diseases, will be required 
during the further course of the pandemic. This is impor-
tant in order to identify recurring interruption in health care 
utilisation, health-related and subjectively-perceived impair-
ments, and to provide appropriate needs-based care for 
people with chronic illnesses.
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intervals), few changes were observed in the utilisation 
of medical services provided by GPs, whereas marked 
changes are identifiable in the case of specialist medical 
services utilisation. One possible explanation for this is 
that necessary visits to GP office for the immediate care 
of diabetes were also largely made during the pandemic 
[11] or could have been replaced by telephone consulta-
tions (and this was also specifically mentioned in the 
question used for data collection). This is consistent with 
the observations in the COSMO study that most people 
with chronic diseases were still able to make the neces-
sary visits to doctors and received the necessary medi-
cation [5]. Additional specialist visits are more likely to 
be occasion-based, such as if complications occur or to 
carry out guideline-based preventive measures (e.g. 
examinations of the ocular fundus every one or two years 
as part of the diabetes disease management programmes 
that have been operating in Germany since 2003/2004 
[12]). Even if the results of this analysis need to be inter-
preted with caution due to the moderate number of cases 
available for each month, accounting data from the Asso-
ciations of SHI Physicians (Kassenärztliche Vereinigun-
gen) also demonstrate that the sharpest decreases 
occurred at the beginning of the pandemic compared to 
the corresponding period of the previous year, especially 
in terms of specialist medical care that required direct 
contact with patients [3]. Alongside the decrease in treat-
ment involving direct contact until the end of May 2020, 
these data also indicate a rise in telephone and video 
consultations, which was interpreted by the authors as 
an adaption in the provision of care [3]. However, spe-
cialist medical examinations (e.g. of the ocular fundus 
No significant decline in  
the utilisation of medical 
services provided by GPs 
among people with diabetes 
was observed during the 
containment period.
People with diabetes have  
a much higher proportion of 
utilising medical services 
provided by GPs and  
specialists than the general 
population – this also 
applied during the  
containment period.
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